YTEN — Yield10 Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00- $0.77m
- $0.16m
- $0.06m
Annual cashflow statement for Yield10 Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13 | -10.2 | -11 | -13.6 | -14.5 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 5.86 | 2.11 | 2.15 | 2.43 | 2.01 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.5 | -0.798 | -0.622 | -0.695 | 2.09 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -8.65 | -8.66 | -9.25 | -11.4 | -10.1 |
| Capital Expenditures | -0.061 | -0.076 | -0.189 | -0.154 | -0.046 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.95 | -0.569 | -4.39 | 8.68 | 1.99 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -3.02 | -0.645 | -4.58 | 8.52 | 1.95 |
| Financing Cash Flow Items | -0.004 | -0.017 | -0.103 | -0.037 | 0.062 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.1 | 7.28 | 15.7 | -0.037 | 6.87 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.39 | -2.06 | 1.91 | -2.97 | -1.29 |